drugset / Trial / NCT00249249

Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels

NCT00249249

Phase 3 Completed 830 enrolled Kowa Research Europe
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy of pitavastatin with that of atorvastatin.

Timeline

Start
2005-10
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg
Subject Atorvastatin Small molecule 20 mg
Subject Pitavastatin Small molecule 2 mg
Subject Pitavastatin Small molecule 4 mg